CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Cash flows from operating activities:
Net loss	$ (75,359)	$ (24,333)
Less: (Loss) income from discontinued operations, net of tax	(25,946)	16,428
Net loss from continuing operations	(49,413)	(40,761)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization expense	4,848	1,728
Stock-based compensation expense	5,438	4,569
Provision adjustments related to credit loss	193	171
Provision adjustments related to product warranty	120	17
Loss on disposal of property, plant, and equipment	(1,147)	0
Impairment charge	22,612	2,956
Total non-cash adjustments	32,064	9,441
Changes in operating assets and liabilities:
Accounts receivable	(1,946)	1,563
Contract assets	(4,599)	(3,393)
Inventory	(5,989)	2,380
Other assets	3,197	131
Accounts payable	(522)	1,097
Contract liabilities	(3,670)	2,650
Operating lease liabilities - current	862	(381)
Accrued expenses and other current liabilities	(254)	3,015
Total change in operating assets and liabilities	(12,921)	7,062
Net cash used in operating activities - continuing operations	(30,270)	(24,258)
Net cash (used in) provided by operating activities - discontinued operations	(3,367)	28,483
Net cash used in operating activities - continuing operations	(33,637)	4,225
Cash flows from investing activities:
Purchase of equipment	(1,856)	(3,079)
Acquisition of business, net of cash acquired	96	(59,861)
Proceeds from disposal of property, plant, and equipment	10,915	0
Net cash provided by (used in) investing activities - continuing operations	9,155	(62,940)
Net cash provided by investing activities - discontinued operations	315	243
Net cash provided by (used in) investing activities - continuing operations	9,470	(62,697)
Cash flows from financing activities:
Proceeds from borrowings of credit facilities	393	22,715
Payments towards credit facilities	(3,507)	(7,222)
Payments towards borrowings from financing payable	(2,731)	0
Payments to Notes Payable Borrowing	(639)	0
Proceeds from sale of common stock	34,249	29
Issuance cost associated with sale of common stock	(3,201)	0
Taxes paid related to net share settlement of equity awards	(164)	(322)
Net cash provided by financing activities	24,400	15,200
Effect of exchange rate changes provided by foreign currency	854	(317)
Net (decrease) increase in cash, cash equivalents and restricted cash	1,087	(43,589)
Cash, cash equivalents, and restricted cash at beginning of period	25,619	69,208
Cash, cash equivalents, and restricted cash at end of period	26,706	25,619
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION
Cash paid during the period for interest	1,230	280
Cash paid during the period for income taxes	146	574
NON-CASH INVESTING AND FINANCING ACTIVITIES
Changes in accounts payable related to purchases of equipment	(373)	(352)
Changes in accounts payable related to financing	$ 460	$ 0